Welcome to our dedicated page for Xylem SEC filings (Ticker: XYL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Xylem Inc. (NYSE: XYL) is a Fortune 500 global water solutions company that reports its financial and operational information to the U.S. Securities and Exchange Commission. The XYL SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, along with AI-powered tools that help explain the content and context of each document.
Among the key filings for Xylem are its Form 10-K annual reports, which typically include a comprehensive discussion of the business, risk factors, and financial statements, and Form 10-Q quarterly reports, which update investors on revenue, margins, cash flows, and segment performance. For example, Xylem’s third-quarter 2025 results were furnished to the SEC via a Form 8-K that referenced its earnings press release and discussed revenue from products and services, adjusted earnings per share, and adjusted EBITDA margin.
The company also files Form 8-K current reports to announce material events such as quarterly results, portfolio transactions, and other significant developments. Recent 8-K filings have covered financial results for quarters ended June 30 and September 30, 2025, with exhibits that include the full text of related press releases.
On this page, users can review Xylem’s historical and ongoing SEC submissions, including annual and quarterly reports, current reports, and other required documents. Stock Titan’s AI-generated summaries highlight important sections, clarify technical language, and point out items that may be relevant to investors, such as segment commentary, outlook statements, and references to restructuring or portfolio optimization.
In addition, the filings page can surface insider transaction reports (Form 4) and proxy-related disclosures when available, helping users monitor equity awards, share ownership changes, and governance matters. Real-time updates from EDGAR combined with AI analysis make it easier to navigate Xylem’s filings and understand how the company communicates its financial condition, risks, and strategic priorities to regulators and the market.
Xylem Inc. director Jerome A. Peribere executed an open-market purchase of 1,210 shares of common stock at $116.61 per share through the Jerome A Peribere 2016 Revocable TR, an indirect ownership vehicle.
Following this transaction, his indirect holdings through the trust total 27,209 common shares, while a separate line shows 4,036 common shares held directly. The scale of the purchase is modest relative to his overall reported position, indicating a routine addition rather than a transformational change in ownership.
Xylem Inc. ownership disclosed: Vanguard Capital Management reports beneficial ownership of 18,193,892 shares of Common Stock, representing 7.48% of the class as reported. The filing states Vanguard has sole dispositive power for 18,193,892 shares and sole voting power for 2,376,964 shares. The report is signed and dated 04/30/2026.
Xylem Inc. multiple Vanguard entities reported beneficial ownership of 12,800,726 shares of Common Stock, representing 5.26% of the class, on a Schedule 13G filing. The filing states Vanguard Portfolio Management LLC has sole dispositive power over 12,800,726 shares and sole voting power of 29,497 shares.
The filing explains these holdings reflect securities held across Vanguard funds and managed accounts for which Vanguard Portfolio Management LLC or affiliated business divisions exercise dispositive authority. The disclosure is signed by the Head of Global Fund Administration and dated 04/29/2026.
Xylem Inc. reported first-quarter 2026 revenue of $2,125 million, up 2.7% from $2,069 million a year earlier. Most of the increase came from favorable foreign currency of $65 million, while organic revenue slipped 0.4%.
Net income attributable to Xylem rose to $193 million from $169 million, with earnings per diluted share increasing to $0.79 from $0.69. Net margin improved to 9.1% and adjusted EBITDA margin edged up to 20.6%.
Water Infrastructure, Applied Water, and Measurement and Control Solutions all posted modest revenue growth, while Water Solutions and Services was roughly flat as weaker U.S. capital project activity and lower opening backlog offset strength in other areas. The company generated $108 million of operating cash flow and invested $90 million in capital expenditures, while also repurchasing 4.8 million shares for $595 million.
Xylem Inc. reported first-quarter 2026 revenue of $2,125 million, up 2.7% from $2,069 million a year earlier. Most of the increase came from favorable foreign currency of $65 million, while organic revenue slipped 0.4%.
Net income attributable to Xylem rose to $193 million from $169 million, with earnings per diluted share increasing to $0.79 from $0.69. Net margin improved to 9.1% and adjusted EBITDA margin edged up to 20.6%.
Water Infrastructure, Applied Water, and Measurement and Control Solutions all posted modest revenue growth, while Water Solutions and Services was roughly flat as weaker U.S. capital project activity and lower opening backlog offset strength in other areas. The company generated $108 million of operating cash flow and invested $90 million in capital expenditures, while also repurchasing 4.8 million shares for $595 million.
Xylem Inc. reported first-quarter 2026 revenue of $2.125 billion, up 3% year over year and flat on an organic basis. Net income attributable to Xylem was $193 million, or $0.79 per share, a 14% increase. Adjusted diluted EPS was $1.12, up 9%.
Net income margin rose to 9.1%, while adjusted EBITDA margin reached 20.6%, a 20 basis point improvement. Xylem now forecasts full-year 2026 revenue of $9.2–$9.3 billion, up about 2–3% on a reported basis, and maintains adjusted EPS guidance of $5.35–$5.60 and free cash flow margin of 10.2–11.0%.
Xylem Inc. reported first-quarter 2026 revenue of $2.125 billion, up 3% year over year and flat on an organic basis. Net income attributable to Xylem was $193 million, or $0.79 per share, a 14% increase. Adjusted diluted EPS was $1.12, up 9%.
Net income margin rose to 9.1%, while adjusted EBITDA margin reached 20.6%, a 20 basis point improvement. Xylem now forecasts full-year 2026 revenue of $9.2–$9.3 billion, up about 2–3% on a reported basis, and maintains adjusted EPS guidance of $5.35–$5.60 and free cash flow margin of 10.2–11.0%.
Xylem Inc. is asking shareholders to vote at its virtual 2026 Annual Meeting on May 14, 2026, while highlighting record 2025 performance and governance practices. Revenue reached $9.0 billion, up 6% reported and 5% organically, with net income margin of 10.6% and adjusted EBITDA margin of 22.2%.
EPS was $3.92 (GAAP) and $5.08 on an adjusted basis, supported by record orders over $8.9 billion and a $4.6 billion backlog. Xylem returned $391 million to shareholders via 2025 dividends and achieved the full $140 million Evoqua cost synergy run-rate one year ahead of target.
Shareholders will vote on electing nine directors, ratifying Deloitte & Touche LLP as auditor, approving named executive officer compensation, and implementing a new 2026 Employee Stock Purchase Plan covering up to 4,000,000 shares at a 15% discount to market. The Board recommends voting FOR all four proposals.
Xylem Inc: The Vanguard Group filed Amendment No. 14 to its Schedule 13G/A reporting 0% ownership of Common Stock. The filing states that on January 12, 2026 Vanguard undertook an internal realignment and certain subsidiaries will report beneficial ownership separately in accordance with SEC Release No. 34-39538 (January 12, 1998). The filing lists Amount beneficially owned: 0 and is signed by Ashley Grim, Head of Global Fund Administration.
Xylem Inc. SVP and Chief Accounting Officer Geri-Michelle McShane reported a small share disposition tied to taxes, not an open-market trade. On the reported date, 64 shares of Xylem common stock were withheld at a price of $126.19 per share to cover tax liabilities from vesting restricted stock units. After this tax-withholding disposition, she held 4,727 Xylem common shares directly.
Xylem Inc. executive vice president Claudia S. Toussaint reported a tax-related share disposition. On March 5, 2026, 305 shares of common stock were withheld at $126.19 per share to cover taxes on restricted stock units that vested under the Xylem 2011 Omnibus Incentive Plan.
After this withholding, Toussaint directly holds 9,037 common shares and indirectly holds 31,250 common shares through the Claudia S. Toussaint Revocable Trust.
Xylem Inc. executive Hayati Yarkadas reported a small tax-related share disposition. On March 5, 2026, 41 shares of Xylem common stock were withheld to cover tax liabilities tied to the vesting of restricted stock units granted on March 5, 2025 under the Xylem 2011 Omnibus Incentive Plan. After this non-market, tax-withholding disposition, Yarkadas directly owned 33,540 Xylem shares.